Chad J. Kolean
Director of Finance/CFO bij CELLECTAR BIOSCIENCES, INC.
Vermogen: 169 460 $ op 31-03-2024
Profiel
Chad J.
Kolean is currently the Chief Financial Officer, Secretary & VP at Cellectar Biosciences, Inc. He previously held positions as the Director-Financial Reporting at Resolve Surgical Technologies, Inc. from 2009 to 2010, the Chief Financial Officer & Treasurer at Resolve Surgical Technologies, Inc. from 2012 to 2013, the Chief Financial Officer at Titan Spine, Inc. from 2017 to 2019, the Controller at TomoTherapy, Inc. from 2010 to 2011, and the CFO, Treasurer & Principal Accounting Officer at Cellectar Biosciences, Inc. from 2014 to 2017.
He also served as the Chief Financial Officer at Vivex Biologics, Inc. from 2019 to 2022.
Mr. Kolean obtained his undergraduate degree from Hope College.
Bekende belangen in openbare bedrijven
Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
---|---|---|---|---|
08-12-2023 | 42 578 ( 0.35% ) | 169 460 $ | 31-03-2024 |
Actieve functies van Chad J. Kolean
Bedrijven | Functie | Begin |
---|---|---|
CELLECTAR BIOSCIENCES, INC. | Director of Finance/CFO | 23-02-2022 |
Eerdere bekende functies van Chad J. Kolean
Bedrijven | Functie | Einde |
---|---|---|
Vivex Biologics, Inc.
Vivex Biologics, Inc. BiotechnologyHealth Technology Vivex Biologics, Inc. is a regenerative medicine company that specializes in developing naturally sourced treatment options and solutions to improve clinical, surgical, and therapeutic patient care through innovation. The company is based in Atlanta, GA and has subsidiaries in the United States. The company leverages the resources of the nation's oldest civilian tissue bank to channel the body's inherent healing qualities and provide medical professionals and patients with innovative treatment options for a broad range of indications. With tissue damage resulting from a variety of diseases, direct injury, and trauma, there is a significant need for advanced solutions. The company was founded by Tracy S. Anderson, and Peter L. Wehrly has been the CEO of the company since 2019. | Director of Finance/CFO | 01-01-2022 |
Titan Spine, Inc.
Titan Spine, Inc. Medical SpecialtiesHealth Technology Titan Spine, Inc. designs and manufactures inter body fusion devices for the spine. The firm specializes in surface technology, medical devices, interbody spinal fusion devices. The company was founded by Peter Ullrich and Kevin W. Gemas in 2005 and is headquartered in Mequon, WI. | Director of Finance/CFO | 01-09-2019 |
CELLECTAR BIOSCIENCES, INC. | Director of Finance/CFO | 05-09-2017 |
Resolve Surgical Technologies, Inc.
Resolve Surgical Technologies, Inc. Medical SpecialtiesHealth Technology Resolve Surgical Technologies, Inc. develops and manufactures medical devices. It provides products in the spine, biologics, orthopedics, and cardiothoracic markets. The company was founded in 1992 and is headquartered in Marquette, MI. | Director of Finance/CFO | 01-07-2013 |
TomoTherapy, Inc.
TomoTherapy, Inc. Medical SpecialtiesHealth Technology TomoTherapy, Inc. manufactures and provides radiation treatment systems for advanced radiation therapy. It provides radiation treatment services for cancer patients with its TomoTherapy Hi·Art System, which changes the intensity of the radiation beam so that it adapts to the shape of the tumor. The firm's system focuses on killing cancer cells while sparing healthy tissue. The company was founded by Thomas Rockwell Mackie and Paul J. Reckwerdt in 1997 and is headquartered in Madison, WI. | Comptroller/Controller/Auditor | 01-08-2011 |
Opleiding van Chad J. Kolean
Hope College | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Beursgenoteerde bedrijven | 1 |
---|---|
CELLECTAR BIOSCIENCES, INC. | Health Technology |
Bedrijven in privébezit | 4 |
---|---|
Resolve Surgical Technologies, Inc.
Resolve Surgical Technologies, Inc. Medical SpecialtiesHealth Technology Resolve Surgical Technologies, Inc. develops and manufactures medical devices. It provides products in the spine, biologics, orthopedics, and cardiothoracic markets. The company was founded in 1992 and is headquartered in Marquette, MI. | Health Technology |
Titan Spine, Inc.
Titan Spine, Inc. Medical SpecialtiesHealth Technology Titan Spine, Inc. designs and manufactures inter body fusion devices for the spine. The firm specializes in surface technology, medical devices, interbody spinal fusion devices. The company was founded by Peter Ullrich and Kevin W. Gemas in 2005 and is headquartered in Mequon, WI. | Health Technology |
TomoTherapy, Inc.
TomoTherapy, Inc. Medical SpecialtiesHealth Technology TomoTherapy, Inc. manufactures and provides radiation treatment systems for advanced radiation therapy. It provides radiation treatment services for cancer patients with its TomoTherapy Hi·Art System, which changes the intensity of the radiation beam so that it adapts to the shape of the tumor. The firm's system focuses on killing cancer cells while sparing healthy tissue. The company was founded by Thomas Rockwell Mackie and Paul J. Reckwerdt in 1997 and is headquartered in Madison, WI. | Health Technology |
Vivex Biologics, Inc.
Vivex Biologics, Inc. BiotechnologyHealth Technology Vivex Biologics, Inc. is a regenerative medicine company that specializes in developing naturally sourced treatment options and solutions to improve clinical, surgical, and therapeutic patient care through innovation. The company is based in Atlanta, GA and has subsidiaries in the United States. The company leverages the resources of the nation's oldest civilian tissue bank to channel the body's inherent healing qualities and provide medical professionals and patients with innovative treatment options for a broad range of indications. With tissue damage resulting from a variety of diseases, direct injury, and trauma, there is a significant need for advanced solutions. The company was founded by Tracy S. Anderson, and Peter L. Wehrly has been the CEO of the company since 2019. | Health Technology |